CSL · 17 hours ago
Manager, Global Reporting & Business Intelligence
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. In this role, you will oversee the design, implementation, and management of data analytics and performance reporting systems, collaborating with multiple departments to provide actionable insights for decision-making.
BiotechnologyHealth CareHealth DiagnosticsMedical
Responsibilities
Oversee the creation and maintenance of performance dashboards and reports to track KPIs across commercial functions like Pricing or Sales Operations
Collaborate with cross-functional teams to ensure data needs are met and insights are communicated effectively to support decision-making
Ensure data quality, governance, and integration from diverse internal and external sources for unified reporting
Lead BI projects, managing timelines, deliverables, and alignment with business objectives
Implement predictive analytics and advanced reporting techniques to provide actionable insights for business strategies
Provide mentorship and guidance to BI team members, promoting continuous improvement and innovation in reporting practices
Ensure compliance with regulatory requirements in all data management and reporting activities
Qualification
Required
Bachelor's or master's degree in computer science, Information Management, Math, Statistics, or a related field
3-5 years of experience in relevant analytics roles and prior BI/reporting team lead experience preferred
Experience with pharmaceutical industry data sources (e.g., IQVIA DDD / Midas, Claims, LRx / Dx) is required
Exceptional communication and interpersonal skills, with the ability to actively engage and influence partners at all levels
Excellent leadership and team management skills, with the ability to inspire and develop impactful teams
Preferred
Strong analytical as well as BI tools (Tableau, Power BI, Qlik etc.) experience preferred
Experience with regulatory compliance related to data privacy and protection
Company
CSL
CSL develops innovative biotherapies and influenza vaccines that save lives, and help people with life-threatening medical conditions.
Funding
Current Stage
Public CompanyTotal Funding
$111M2013-12-20Acquired
2004-02-06Post Ipo Equity· $111M
1994-06-03IPO
Recent News
Pharma Letter
2026-01-03
2025-10-29
Company data provided by crunchbase